These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23243272)

  • 1. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
    Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
    Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans.
    Hofbauer CJ; Whelan SF; Hirschler M; Allacher P; Horling FM; Lawo JP; Oldenburg J; Tiede A; Male C; Windyga J; Greinacher A; Knöbl PN; Schrenk G; Koehn J; Scheiflinger F; Reipert BM
    Blood; 2015 Feb; 125(7):1180-8. PubMed ID: 25515962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
    Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
    Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
    van Helden PM; van den Berg HM; Gouw SC; Kaijen PH; Zuurveld MG; Mauser-Bunschoten EP; Aalberse RC; Vidarsson G; Voorberg J
    Br J Haematol; 2008 Aug; 142(4):644-52. PubMed ID: 18510679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay.
    Pezeshkpoor B; Berkemeier AC; Herbst K; Albert T; Müller J; Oldenburg J
    J Thromb Haemost; 2024 Jun; 22(6):1591-1604. PubMed ID: 38453023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell memory against factor VIII.
    Reipert BM
    Cell Immunol; 2016 Mar; 301():49-58. PubMed ID: 26780996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
    Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; ;
    J Thromb Haemost; 2015 Jan; 13(1):47-53. PubMed ID: 25354263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.
    Lin PC; Liao YM; Tsai SP; Chang TT
    Pediatr Blood Cancer; 2011 Dec; 57(6):1029-33. PubMed ID: 21793191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
    Sahud M; Zhukov O; Mo K; Popov J; Dlott J
    Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.
    Lewis KB; Hughes RJ; Epstein MS; Josephson NC; Kempton CL; Kessler CM; Key NS; Howard TE; Kruse-Jarres R; Lusher JM; Walsh CE; Watts RG; Ettinger RA; Pratt KP;
    PLoS One; 2013; 8(5):e61120. PubMed ID: 23667433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell-activating factor modulates the factor VIII immune response in hemophilia A.
    Doshi BS; Rana J; Castaman G; Shaheen MA; Kaczmarek R; Butterfield JS; Meeks SL; Leissinger C; Biswas M; Arruda VR
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33651716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
    Oomen I; Verhagen M; Miranda M; Allacher P; Beckers EAM; Blijlevens NMA; van der Bom JG; Coppens M; Driessens M; Eikenboom JCJ; Fijnvandraat K; Hassan S; van Heerde WL; Hooimeijer HL; Jansen JH; Kaijen P; Leebeek FWG; Meijer D; Paul H; Rijpma SR; Rosendaal FR; Smit C; van Vulpen LFD; Voorberg J; Schols SEM; Gouw SC
    Front Immunol; 2024; 15():1355813. PubMed ID: 38455035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerating Factor VIII: Recent Progress.
    Lacroix-Desmazes S; Voorberg J; Lillicrap D; Scott DW; Pratt KP
    Front Immunol; 2019; 10():2991. PubMed ID: 31998296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors.
    Hofbauer CJ; Kepa S; Schemper M; Quehenberger P; Reitter-Pfoertner S; Mannhalter C; Reipert BM; Pabinger I
    Blood; 2016 Jul; 128(2):293-6. PubMed ID: 27216215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.
    Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Donfield SM; Astermark J; Berntorp E; Lollar P; Schwabe D; Königs C
    Haemophilia; 2017 Mar; 23(2):292-299. PubMed ID: 27862687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG subclasses of FVIII inhibitors in an argentine cohort of severe hemophilia A patients: Analysis by flow cytometry.
    Irigoyen MB; Primiani L; Felippo M; Candela M; de Bracco MME; Galassi NV
    Int J Lab Hematol; 2017 Dec; 39(6):569-576. PubMed ID: 28612430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.